Hypertension in Elderly Diabetic Subjects
- 121 Downloads
Diabetes and hypertension often coexist and their association consistently favors cardiovascular disease (CVD) and chronic renal disease. Control of blood pressure to a level of 140/90 mm Hg in people with diabetes can prevent or at least delay CVD and chronic kidney disease. In the past, treatment guidelines have stressed tight blood pressure control (±130/80) for people with diabetes. These recommendations have not been constantly supported by recent large randomized control trials, especially in the elderly. Here we review the recent literature regarding the benefits of blood pressure control in elderly patients with diabetes mellitus. We further focus on evidence for specific recommendations in this population subset.
Compliance with Ethics Guidelines
Conflict of Interest
Michel E. Safar declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C, American Heart A, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.PubMedCrossRefGoogle Scholar
- 3.Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med. 2005;165:875–82.PubMedCrossRefGoogle Scholar
- 4.Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995;91:1432–43.PubMedCrossRefGoogle Scholar
- 18.Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757–64.PubMedCrossRefGoogle Scholar
- 23.• Sowers JR. Diabetes mellitus and vascular disease. Hypertension. 2013;61:943–947. This reference highlights the main results of the present commentary.Google Scholar